These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37566020)

  • 41. Sequence Polymorphism in Xenobiotic Metabolising Genes in Iraqi Colorectal Cancer Patients.
    Ibrahem SQ; Al-Dalawi ZT; Bahaaldin AS
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1203-1210. PubMed ID: 33906313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer.
    Eilertsen IA; Sveen A; Strømme JM; Skotheim RI; Nesbakken A; Lothe RA
    Int J Cancer; 2019 Feb; 144(4):841-847. PubMed ID: 30121958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases.
    Lahti SJ; Xing M; Zhang D; Lee JJ; Magnetta MJ; Kim HS
    J Vasc Interv Radiol; 2015 Aug; 26(8):1102-11. PubMed ID: 26210240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of novel advanced glycation end products receptor gene variants associated with colorectal cancer in Tunisians: A case-control study.
    Bedoui SA; Barbirou M; Stayoussef M; Dallel M; Mokrani A; Makni L; Mezlini A; Bouhaouala-Zahar B; Yacoubi-Loueslati B; Almawi WY
    Gene; 2020 Sep; 754():144893. PubMed ID: 32544495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between genetic variants in pre-miRNA and colorectal cancer risk in a Chinese population.
    Lv M; Dong W; Li L; Zhang L; Su X; Wang L; Gao L; Zhang L
    J Cancer Res Clin Oncol; 2013 Aug; 139(8):1405-10. PubMed ID: 23728616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation between DPYD gene variation and KRAS wild type status in colorectal cancer.
    Kleist B; Kempa M; Meurer T; Poetsch M
    J Clin Pathol; 2016 Mar; 69(3):204-8. PubMed ID: 26281864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. miRNAs-Based Molecular Signature for
    Milanesi E; Dobre M; Bucuroiu AI; Herlea V; Manuc TE; Salvi A; De Petro G; Manuc M; Becheanu G
    J Immunol Res; 2020; 2020():4927120. PubMed ID: 32676506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
    Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Susceptibility to Colorectal Cancer and Two Genetic Polymorphisms of XRCC4.
    Emami N; Saadat I; Omidvari S
    Pathol Oncol Res; 2015 Sep; 21(4):881-5. PubMed ID: 25662981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of miRNA targetome variants in LAMC1 and GNB3 genes with colorectal cancer and obesity.
    Gholami M; Zoughi M; Behboo R; Taslimi R; Kazemeini A; Bastami M; Hasani-Ranjbar S; Larijani B; Amoli MM
    Cancer Med; 2022 Nov; 11(21):3923-3938. PubMed ID: 35373932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The association between survivin -31G>C polymorphism and susceptibility to sporadic colorectal cancer in a Southern Chinese population.
    Huang J; Wei Y; Zhou X; Wang L; Huang M; Wang J
    J Cancer Res Ther; 2019; 15(1):82-86. PubMed ID: 30880759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of KRAS protein expression by miR-544a and KRAS-LCS6 polymorphism in wild-type KRAS sporadic colon adenocarcinoma.
    Marinović S; Škrtić A; Catela Ivković T; Poljak M; Kapitanović S
    Hum Cell; 2021 Sep; 34(5):1455-1465. PubMed ID: 34235620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of KRAS mutation with tumor deposit status and overall survival of colorectal cancer.
    Zhang M; Hu W; Hu K; Lin Y; Feng Z; Yun JP; Gao N; Zhang L
    Cancer Causes Control; 2020 Jul; 31(7):683-689. PubMed ID: 32394229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2.
    Liao WT; Ye YP; Zhang NJ; Li TT; Wang SY; Cui YM; Qi L; Wu P; Jiao HL; Xie YJ; Zhang C; Wang JX; Ding YQ
    J Pathol; 2014 Mar; 232(4):415-27. PubMed ID: 24293274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship Between 18F-FDG PET/CT Scans and KRAS Mutations in Metastatic Colorectal Cancer.
    Kawada K; Toda K; Nakamoto Y; Iwamoto M; Hatano E; Chen F; Hasegawa S; Togashi K; Date H; Uemoto S; Sakai Y
    J Nucl Med; 2015 Sep; 56(9):1322-7. PubMed ID: 26135109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors Associated With Guideline-recommended KRAS Testing in Colorectal Cancer Patients: A Population-based Study.
    Charlton ME; Karlitz JJ; Schlichting JA; Chen VW; Lynch CF
    Am J Clin Oncol; 2017 Oct; 40(5):498-506. PubMed ID: 25844824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deregulation of the miR-16-KRAS axis promotes colorectal cancer.
    You C; Liang H; Sun W; Li J; Liu Y; Fan Q; Zhang H; Yue X; Li J; Chen X; Ba Y
    Sci Rep; 2016 Nov; 6():37459. PubMed ID: 27857191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between
    Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
    World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
    [TBL] [Abstract][Full Text] [Related]  

  • 59. KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behavior.
    Jang S; Hong M; Shin MK; Kim BC; Shin HS; Yu E; Hong SM; Kim J; Chun SM; Kim TI; Choi KC; Ko YW; Kim JW
    Hum Pathol; 2017 Jul; 65():21-30. PubMed ID: 28188750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population.
    Sinha R; Hussain S; Mehrotra R; Kumar RS; Kumar K; Pande P; Doval DC; Basir SF; Bharadwaj M
    PLoS One; 2013; 8(4):e60142. PubMed ID: 23573237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.